Cardiovascular Benefits Some GLP-1 medications have demonstrated cardiovascular benefits, such as reducing the risk of heart attack, stroke, and other cardiovascular events
patent is expected to expire in 2032
And as recently as April, industry giant Pfizer halted its development of a GLP-1 competitor following reports of drug-induced liver injury
John Salerno Personalized Semaglutide or Tirzepatide Medical Treatments for Weight Loss and Diabetes Management in Manhattan, NY and Connecticut For over thirty years, I have been dedicated to helping my patients achieve better glycemic control and improve their overall health through personalized treatment plans
The Upfront Multi-Month Commitment To secure the lowest advertised price on some major telehealth platforms, patients are forced to pay for multiple months of treatment upfront
When titrated thoughtfully, it becomes much easier to manage side effects while still moving toward meaningful weight-loss outcomes